Evidence map›Paper›PMID 38263463›Full record

ArticleNature immunology2024

Lithium carbonate revitalizes tumor-reactive CD8

Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
40.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Review
  3. Compartmental pH regulation in cancer and antitumor immunity: therapeutic opportunities and challenges.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Article
  5. Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Identification ofMolecular medicine reports · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Regulators of CD8Nature reviews. Immunology · 2026
    Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Jingwei Ma *Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liang Tang *Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yaoyao Tan *Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jingxuan XiaoDepartment of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Keke WeiDepartment of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xin ZhangDepartment of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuan MaDepartment of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shuai TongDepartment of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jie ChenDepartment of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Nannan ZhouDepartment of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li YangBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang LeiDepartment of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yonggang LiHubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
Jiadi LvDepartment of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Junwei LiuCardiovascular Surgery, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Huafeng ZhangDepartment of Pathology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ke TangDepartment of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yi ZhangBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID http://orcid.org/0000-0001-9861-4681
Bo HuangDepartment of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tjhuangbo@hotmail.com.ORCID http://orcid.org/0000-0001-8476-1138
Huazhong University of Science and Technology · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNFirst Affiliated Hospital of Zhengzhou University · CNCentral Hospital of Wuhan · CNHubei Provincial Center for Disease Control and Prevention · CNUnion Hospital · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32090053National Natural Science Foundation of China (National Science Foundation of China) 82388201National Natural Science Foundation of China (National Science Foundation of China) 91942314
6 · The paper itself

Abstract

The steady flow of lactic acid (LA) from tumor cells to the extracellular space via the monocarboxylate transporter symport system suppresses antitumor T cell immunity. However, LA is a natural energy metabolite that can be oxidized in the mitochondria and could potentially stimulate T cells. Here we show that the lactate-lowering mood stabilizer lithium carbonate (LC) can inhibit LA-mediated CD8

Indexed as

Antimanic AgentsLactic AcidLithium CarbonateMitochondriaNeoplasmsCD8-Positive T-LymphocytesHumansAntimanic AgentsLactic AcidLithium Carbonate

Identifiers

PMID38263463
PMCPMC10907288
OpenAlexW4391174617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.